Streetbeat News

Legal

HAS

Hasbro, Inc. is facing a lawsuit for alleged securities law violations. Investors who suffered losses are encouraged to contact Levi & Korsinsky by January 13, 2025, to discuss potential recovery options.

Portfolio Pulse from

January 10, 2025 | 3:00 pm

AZN

A securities fraud class action lawsuit is pending against AstraZeneca PLC. Investors who suffered losses can contact Levi & Korsinsky before February 21, 2025, to discuss potential recovery under federal securities laws.

Portfolio Pulse from

January 10, 2025 | 3:00 pm

PACS

PACS Group, Inc. is facing a lawsuit for securities law violations. Investors who suffered losses are encouraged to contact Levi & Korsinsky by January 13, 2025, to discuss potential recovery options.

Portfolio Pulse from

January 10, 2025 | 3:00 pm

HUMA

A class action lawsuit has been filed against Humacyte, Inc. (HUMA) for potential recovery under federal securities laws. Investors who suffered losses are encouraged to contact Levi & Korsinsky for more information.

Portfolio Pulse from

January 10, 2025 | 3:00 pm

ANRO

Alto Neuroscience Inc is under investigation by The Schall Law Firm for potential securities law violations. The investigation is centered on whether the company issued misleading statements or failed to disclose important information to investors.

Portfolio Pulse from

January 10, 2025 | 3:00 pm

ZUO

The Schall Law Firm is investigating Zuora, Inc. for potential breaches of fiduciary duty by its directors and management. The inquiry aims to determine if the board failed in its responsibilities to shareholders.

Portfolio Pulse from

January 10, 2025 | 2:45 pm

ATUSF

Altius Minerals Corporation has received a partial award decision from an Arbitration Tribunal regarding its royalty interests in the Silicon gold district in Nevada. The arbitration involves Altius Royalty Corporation and AngloGold Ashanti North America Inc.

Portfolio Pulse from

January 10, 2025 | 2:45 pm

AZN

AstraZeneca (AZN) is facing a securities class action lawsuit in the US following reports of a probe by Chinese regulators into alleged illegal activities, including drug imports and health insurance fraud. This has led to a 15% decline in its stock price over the past six months.

Portfolio Pulse from

January 10, 2025 | 2:45 pm

ASPI

ASP Isotopes Inc. (NASDAQ: ASPI) is facing allegations from activist short-seller Fuzzy Panda Research, accusing the company of misleading investors with false claims about its nuclear technology. Despite a rebuttal from ASPI, the stock has fallen 16% in the past five days and 40% since the report's release.

Portfolio Pulse from

January 10, 2025 | 2:45 pm

RVNC

Levi & Korsinsky is inviting investors in Revance Therapeutics, Inc. (NASDAQ:RVNC) who suffered losses to contact them before March 4, 2025, to discuss potential recovery under federal securities laws.

Portfolio Pulse from

January 10, 2025 | 2:45 pm